Upstream Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Upstream Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$2.85M	$2.37M
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$160.36M	-$77.76M
Operating income as a percentage of revenue.	-5618.8%	-3281.2%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$143.44M	-$62.81M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-2.66	$-5.58
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-2.66	$-5.58

Balance Sheet

	2025-12-31	2024-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$101.58M	$325.89M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$353.77M	$481.72M
Everything the company owes — debt, unpaid bills, and other obligations.	$14.00M	$11.87M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$339.77M	$469.85M

Cash Flow Statement

	2025-12-31	2024-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$133.28M	-$59.17M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$165000	$511000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$133.44M	-$59.68M

Peer Comparison

	You	Peer avg
P/E	–	15.5
Revenue Growth	-17.5%	+1381.4%
ROE	-46.1%	-35.5%